Forward Pharma Provides Update on the Decision of the Federal Circuit in its Appeal of the U.S. Patent Interference
Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake
